CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 102 enrolled / 102 target
Drug / intervention
Dexamethasonedrug
Likely dose
0.1 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05136560
NCT05136560Phase 1CompletedOn Track (2.0/mo)Completion was 4mo ago
CompareCT.gov

A Randomized, Double-blind, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis

CHA University·interventional·Posted Nov 29, 2021·Updated Jun 15, 2026

In Brief

A Phase 1 clinical trial evaluating Dexamethasone for Sepsis. Completed, enrolled 102 participants across 2 sites.

Detailed Summary

The purpose of this study is to investigate the safety and efficacy of early administration of two different doses of dexamethasone in high risk septic patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis
CountriesSouth Korea
Collaborators--

Timeline

Phase 1CompletedFinished
20222023202420252026
First PostedNov 29, 2021
Enrollment StartMar 1, 2022
Primary CompletionFeb 28, 2026
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 4.6 years ago

Arms & Interventions

Placebono_intervention

normal saline

low dose dexamethasoneexperimental

0.1 mg/kg dexamethasone iv once per day, for 1 or 2 days

Drug: Dexamethasone
high dose dexamethasoneexperimental

0.2 mg/kg dexamethasone iv once per day, for 1 or 2 days

Drug: Dexamethasone

Interventions

Dexamethasonedrug

Intervention drugs would be administered for 1 or 2 days.